The nation of Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (272 million pounds) over five years over the United States' insistence on sensitive biological samples.
This rejection became public after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government representative has since explained that the US was demanding access to genetic material for scientific study and profit while was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued talks to reach a deal agreeable to both sides so the country's vital HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were raised about the safety of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government deals to boost openness and responsibility.
According to statements, 16 African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Our nation was requested to provide its genetic material and health information indefinitely, without any corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"In essence, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending systems previously set up through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be designed in a way that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that talks must proceed since a large portion of the nation's HIV programmes depended on external financing.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it said.
This impasse underscores the continuing challenges between receiving vital foreign assistance and protecting local interests in an ever more interconnected world.